SCHEMBL8894640

SCHEMBL8894640

CC=C(C(=O)O)c1cc(F)cc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
HCAR1 Q9BXC0 1/20 0.42
AKR1C2 P52895 2/20 0.38
SLC6A3 Q01959 1/20 0.38
HCAR2 Q8TDS4 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
AKR1C3 P42330 2/20 0.36
PTGS2 P35354 1/20 0.36
AKR1C1 Q04828 1/20 0.36
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
GRM5 P41594 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA9 Q16790 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768159 0.83 CES2 (0.50) CES2CES1HCAR1AKR1C2SLC6A3
SCHEMBL4768154 0.83 CES2 (0.50) CES2CES1HCAR1AKR1C2SLC6A3
SCHEMBL4767600 0.80 CES2 (0.43) CES2CES1HCAR1AKR1C2SLC6A3
SCHEMBL4767593 0.80 CES2 (0.43) CES2CES1HCAR1AKR1C2SLC6A3
SCHEMBL8895296 0.80 CES2 (0.57) CES2CES1AKR1C2ALDH1A1AKR1C3
SCHEMBL7942173 0.78 ALDH1A1 (0.56) CES2CES1AKR1C2ALDH1A1HTT
SCHEMBL8893826 0.74 CES2 (0.55) CES2CES1SLC6A3ALDH1A1HTT
SCHEMBL2096388 0.72 CES2 (0.46) CES2CES1HCAR1SLC6A3HCAR2
SCHEMBL4414671 0.72 CES2 (0.75) CES2CES1HCAR1SLC6A3HCAR2
SCHEMBL157714 0.71 HCAR1 (0.73) CES2CES1HCAR1HCAR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670531-A ENKEPHALINASE OR ANGIOTENSIN CONVERTING ENZYME INHIBITORS SOCIETE CIVILE BIOPROJET (FR) 1997-09-23 US disclosed